STING1 and neoplasm: The removal of CD8+ T cells, followed by the knockout of STING in tumors with low immunogenicity, leads to the elimination of STING’s inhibitory effect on these tumors.221 This finding demonstrates that effector cells play a role in STING-mediated tumor protection.